Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bladder Cancer
100%
Bladder Cancer Patients
10%
Cancer Patients
20%
Cancer Tissue
10%
Cancer-related Inflammation
10%
Carbon Tetrachloride
10%
CCL3
10%
CD11b
10%
CD11b+
20%
CD15
30%
CD33
20%
CD4+
10%
Cell Subsets
100%
Chemokine Ligand 2 (CCL2)
10%
Cytokines/chemokines
20%
FoxP3+
10%
Granulocyte Colony-stimulating Factor (G-CSF)
10%
Granulocytes
10%
Granulocytic
30%
Healthy Individuals
10%
HLA-DR
20%
Immune Dysfunction
10%
In Cancer
10%
Inflammation
10%
Interleukin-6
10%
Interleukin-8
10%
Invasive Urothelial Carcinoma
20%
Monocytes
10%
Monocytes/macrophages
10%
Monocytic
10%
Monocytic Myeloid-derived Suppressor Cells (M-MDSCs)
10%
Myeloid Cells
100%
Peripheral Blood
10%
Proinflammatory Chemokines
10%
Regulatory T (Treg) Cells
10%
T Cell Proliferation
10%
Tumor
10%
Tumor Tissue
10%
Tumor-associated Myeloid Cells
100%
Tumor-induced Immune Suppression
10%
Immunology and Microbiology
Cancer Tissue
9%
CCL2
9%
CCL3
9%
CD15
27%
CD33
18%
CD4
9%
Chemokine
18%
Cytokine
18%
Granulocyte
9%
Granulocyte Colony-Stimulating Factor
9%
HLA-DR
18%
Immune System Disorders
9%
In Vitro
9%
Inflammation
18%
Interleukin 6
9%
Interleukin 8
9%
Macrophage
9%
Monocyte
18%
Myeloid
100%
Myeloid-Derived Suppressor Cell
9%
Regulatory T Cell
9%
T Cell Proliferation
9%